About Envol Biomedical

Envol Biomedical, established in 2019, is a growing preclinical contract research organization with a mission to be the leading nonhuman primate research facility in the country for the pharmaceutical industry.

The company has access to the largest population of NHP in the US, with lead times for new studies of 4-6 weeks. The laboratory has capabilities in multiple dose routes (including CNS, ophthalmic), specialized disease models and surgical collections. We have access to NHP resources that include cynomolgus macaque of numerous origins, marmosets, squirrel monkeys and African Green. The laboratory is supported by a clinical pathology and immunology core laboratory. Envol is AAALAC accredited, USDA and OLAW compliant.

Our business model is to provide our clients a high value research partner through speed, customer service and quality. We have a strong workforce that is managed by a leadership team with significant CRO and pharmaceutical industry experience. Envol aims to be GLP compliant in 2025.


Non-human primate preclinical research


Largest population available in the continental U.S.


On time delivery of study samples and study reports


AAALAC accredited, USDA and OLAW compliant

Pharmacology and Toxicology Research Facilities

Envol Biomedical has over 75,000 square feet of laboratory space, including over 40 indoor animal rooms with supporting infrastructure for surgery, necropsy, clinical pathology, immunology, bioanalytical and physiology. Envol has housing that meets European size guidance as well as state-of-the-art socialization housing.



Jake McDonald, PhD, ATS

Chief Executive Officer


Oscar Sanchez

Vice President of Quality Assurance and Regulatory Affairs

Dr. Diana Gerardi Scorpio DVM, MPH, PhD, DACLAM Director of Comparative Medicine and VP for Research

Dr. Alain Stricker-Krongrad, Ph.D., M.Sc.

Technical Advisor and Co-Founder

Bruce Bernacky, DVM

Attending Veterinarian

Technical Area Leads

The leadership at Envol is important because they provide the vision and experience required to meet the needs of our partners. However, the differentiator between Envol Biomedical and other laboratories is the strength, compassion, and care of our staff. There is a culture of care. The teams are genuinely focused on ensuring that the mission and vision of the organizations goals are met, and that they are aligned with the sponsors needs.

Miao Zhong, Ph.D

Pharmacology and Immunology/Bioanalytical

Mason NondorfNHP GLP Toxicology and Safety Pharmacology

David S. Moddrelle

Director of Surgical Research Services